TransMedics Group, Inc. (TMDX): A Bull Case Theory

We came across a bullish thesis on TransMedics Group, Inc. (TMDX) on Substack by Oliver | MMMT Wealth. In this article, we will summarize the bulls’ thesis on TMDX. TransMedics Group, Inc. (TMDX)’s share was trading at $69.15 as of April 7^th. TMDX’s trailing and forward P/E were 64.63 and 45.66 respectively according to Yahoo Finance.

A doctor performing a living donor kidney transplant in a hospital operating room, emphasizing the importance of medical advancements.

TransMedics (TMDX) stands out as one of the most recession- and tariff-proof small-cap medtech companies, with a business model that is increasingly resilient in today’s economic environment. The company manufactures most of its kits in the U.S., minimizing reliance on imports, and is steadily gaining control over its entire supply chain. This operational dominance limits vulnerability to rising flight or logistics costs that typically impact peers. Unlike many in its sector, TMDX has remained remarkably stable, outperforming names like ISRG, PRCT, and LMAT during recent market weakness. This price resilience underlines the defensive strength of its business model. What makes TMDX especially attractive is its high growth—currently expanding at 50%—while trading at only 4.6x forward sales. This compares favorably to ISRG’s 25% growth at 16.5x, PRCT’s 57% at 7.9x but with negative margins, and LMAT’s 14% at 7.0x. Furthermore, flight activity—an indicator of TMDX’s operational volume—is up 20% quarter-over-quarter, suggesting strong Q1 earnings ahead. With the potential for a revenue guidance raise of 10–20% and a solid earnings beat on April 29, the current valuation at $67 per share offers a compelling risk/reward setup.

TransMedics Group, Inc. (TMDX) is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 29 hedge fund portfolios held TMDX at the end of the fourth quarter which was 32 in the previous quarter. While we acknowledge the risk and potential of TMDX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than TMDX but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock.

Disclosure: None. This article was originally published at Insider Monkey.